Evidence map›Paper›PMID 29020091›Full record

ArticlePloS one2017

A novel network analysis approach reveals DNA damage, oxidative stress and calcium/cAMP homeostasis-associated biomarkers in frontotemporal dementia.

Fernando Palluzzi, Raffaele Ferrari, Francesca Graziano, Valeria Novelli, Giacomina Rossi, Daniela Galimberti, Innocenzo Rainero, Luisa Benussi, Benedetta Nacmias, Amalia C Bruni and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Therapeutic Potential ofFood science & nutrition · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Interplay between CaInternational journal of molecular sciences · 2019
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Fernando PalluzziDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0003-0861-5512
Raffaele FerrariDepartment of Molecular Neuroscience, Institute of Neurology, University College London (UCL), London, United Kingdom.
Francesca GrazianoDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.
Valeria NovelliDepartment of Genetics, Fondazione Policlinico A. Gemelli, Roma, Italy.
Giacomina RossiDivision of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Daniela GalimbertiDepartment of Neurological Sciences, Dino Ferrari Institute, University of Milan, Milano, Italy.
Innocenzo RaineroDepartment of Neuroscience, Neurology I, University of Torino and Città della Salute e della Scienza di Torino, Torino, Italy.
Luisa BenussiMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Benedetta NacmiasDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Firenze, Italy.
Amalia C BruniNeurogenetic Regional Centre ASPCZ Lamezia Terme, Lamezia Terme (CZ), Italy.
Daniele CusiDepartment of Health Sciences, University of Milan at San Paolo Hospital, Milano, Italy.
Erika SalviInstitute of Biomedical Technologies, Italian National Research Council, Milano, Italy.
Barbara BorroniDepartment of Medical Sciences, Neurology Clinic, University of Brescia, Brescia, Italy.
Mario GrassiDepartment of Brain and Behavioural Sciences, Medical and Genomic Statistics Unit, University of Pavia, Pavia, Italy.
University of Pavia · ITUniversity of Milan · ITAgostino Gemelli University Polyclinic · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITCentro San Giovanni di Dio Fatebenefratelli · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITInstitute of Biomedical Technologies · ITUniversity College London · GBUniversity of Brescia · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frontotemporal Dementia (FTD) is the form of neurodegenerative dementia with the highest prevalence after Alzheimer's disease, equally distributed in men and women. It includes several variants, generally characterized by behavioural instability and language impairments. Although few mendelian genes (MAPT, GRN, and C9orf72) have been associated to the FTD phenotype, in most cases there is only evidence of multiple risk loci with relatively small effect size. To date, there are no comprehensive studies describing FTD at molecular level, highlighting possible genetic interactions and signalling pathways at the origin FTD-associated neurodegeneration. In this study, we designed a broad FTD genetic interaction map of the Italian population, through a novel network-based approach modelled on the concepts of disease-relevance and interaction perturbation, combining Steiner tree search and Structural Equation Model (SEM) analysis. Our results show a strong connection between Calcium/cAMP metabolism, oxidative stress-induced Serine/Threonine kinases activation, and postsynaptic membrane potentiation, suggesting a possible combination of neuronal damage and loss of neuroprotection, leading to cell death. In our model, Calcium/cAMP homeostasis and energetic metabolism impairments are primary causes of loss of neuroprotection and neural cell damage, respectively. Secondly, the altered postsynaptic membrane potentiation, due to the activation of stress-induced Serine/Threonine kinases, leads to neurodegeneration. Our study investigates the molecular underpinnings of these processes, evidencing key genes and gene interactions that may account for a significant fraction of unexplained FTD aetiology. We emphasized the key molecular actors in these processes, proposing them as novel FTD biomarkers that could be crucial for further epidemiological and molecular studies.

Indexed as

DNA DamageHomeostasisOxidative StressAlgorithmsBiomarkersCalciumCyclic AMPFrontotemporal DementiaHeuristicsHumansMAP Kinase Signaling SystemBiomarkersCalciumCyclic AMP

Identifiers

PMID29020091
PMCPMC5636111
OpenAlexW2763097300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.